LifestyleNews
DUBAI IMPACT:
UAE Oral Wegovy Approval Turns Weight-Loss Demand Into a Clinical Discipline Test
The Emirates Drug Establishment approved Wegovy as an oral semaglutide tablet for long-term weight management in adults in the UAE.
The UAE is only the second country after the United States to approve and receive supply of the once-daily pill, with doctors citing around 17 percent weight loss over about a year for patients who stayed on treatment.
The practical test is whether easier access through a pill format remains tied to clinical screening, diet and physical activity rather than short-term cosmetic use.
